Carhart-HarrisRLBolstridgeMRuckerJ. (2016) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry3: 619–627.
2.
Carhart-HarrisRLLeechRWilliamsTM. (2012) Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. Br J Psychiatry200: 238–244.
3.
FrazerABenmansourS (2002) Delayed pharmacological effects of antidepressants. Mol Psychiatry7: S23–28.
4.
GasserPHolsteinDMichelY. (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis202: 513–520.
5.
GriffithsRRJohnsonMWCarducciMA. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol30: 1181-1197.
6.
GriffithsRRRichardsWAMcCannU. (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology187: 268–283.
7.
GrobCSDanforthALChopraGS. (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry68: 71–78.
NuttDJ (1998) Efficacy of mirtazapine in clinically relevant subgroups of depressed patients. Depress Anxiety7: 7–10.
10.
PandeyGN (2013) Biological basis of suicide and suicidal behavior. Bipolar Disord15: 524–541.
11.
PandeyGNDwivediYRizaviHS. (2002) Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry159: 419–429.
12.
PapakostasGIMartinsonMAFavaM. (2016) Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression. J Clin Psychiatry77: e619–624.
13.
RossSBossisAGussJ. (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol30: 1165-1180.
14.
SilverstonePH (1990) Depression increases mortality and morbidity in acute life-threatening medical illness. J Psychosom Res34: 651–657.
15.
UrbanDJZhuHMarcinkiewczCA. (2016) Elucidation of the behavioral program and neuronal network encoded by dorsal raphe serotonergic neurons. Neuropsychopharmacology41: 1404–1415.
16.
VergoMTWhymanJLiZ. (2016) Assessing preparatory grief in advanced cancer patients as an independent predictor of distress in an American population. J Palliat Med. Epub ahead of print 1Sep2016.
17.
WillinsDLDeutchAYRothBL (1997) Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse27: 79–82.
YamauchiMMiyaraTMatsushimaT. (2006) Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors. Brain Res1067: 164–169.
